• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOSENSE WEBSTER INC NAVI-STAR¿ THERMO-COOL¿ ELECTROPHYSIOLOGY CATHETER; CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FLUTTER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOSENSE WEBSTER INC NAVI-STAR¿ THERMO-COOL¿ ELECTROPHYSIOLOGY CATHETER; CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FLUTTER Back to Search Results
Model Number NI75TCDH
Device Problem Patient Device Interaction Problem (4001)
Patient Problem Cardiac Tamponade (2226)
Event Date 08/01/2022
Event Type  Injury  
Manufacturer Narrative
If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's ref.# pc-(b)(4).
 
Event Description
It was reported that a patient underwent a ventricular tachycardia (vt) ablation procedure with a navi-star¿ thermo-cool¿ electrophysiology catheter and the patient suffered cardiac tamponade requiring pericardiocentesis.Map of right ventricle (rv) and left ventricle (lv) was done with pentaray catheter.Then they started ablation with navi-star¿ thermo-cool¿ electrophysiology catheter in the rv.The ablations were close to the implantable cardioverter defibrilators (icd) lead in the rv.After six ablation points, physician did an ultrasound and an epicardial effusion is noticed.A pericardiocentesis was performed.When the hemodynamics of the patient were stable again, physician continue the ablation phase in the lv.Vt was not inducible anymore, and the procedure was finished.Patient was stable at the end of the case.
 
Manufacturer Narrative
On 1-sep-2022, the bwi product analysis lab received the complaint device for evaluation.The product analysis has begun but is not completed at this time.When the investigational analysis has been completed, a supplemental 3500a report will be submitted.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's ref.# (b)(4).
 
Manufacturer Narrative
It was reported that a patient underwent a ventricular tachycardia (vt) ablation procedure with a navi-star¿ thermo-cool¿ electrophysiology catheter and the patient suffered cardiac tamponade requiring pericardiocentesis.Map of right ventricle (rv) and left ventricle (lv) was done with pentaray catheter.Then they started ablation with navi-star¿ thermo-cool¿ electrophysiology catheter in the rv.The ablations were close to the implantable cardioverter defibrillators (icd) lead in the rv.After six ablation points, physician did an ultrasound and an epicardial effusion is noticed.A pericardiocentesis was performed.Device evaluation details: the product was returned to biosense webster inc (bwi) for evaluation and the evaluation has been completed.A visual inspection and an evaluation of all features of the device were performed following bwi procedures.Visual analysis revealed no damage or anomalies on the device.Per the event, several tests were performed.The magnetic, temperature features were tested and no issues were observed.In addition, the product was deflecting and irrigating correctly.No malfunctions were observed during the product analysis.A manufacturing record evaluation was performed for the finished device batch number, and no internal actions were identified.No malfunction was observed during the product analysis.The root cause of the adverse event remains unknown.There may have been other circumstances or issues that occurred during the use of the device that could not be replicated during the analysis.The ifu (instruction for use) states that careful catheter manipulation must be performed to avoid cardiac damage, perforation or tamponade.The root cause of the adverse event remains unknown.There may have been other circumstances or issues that occurred during the use of the device that could not be replicated during the analysis.As part of biosense webster¿s quality process, all devices are manufactured, inspected, and released to approved specifications.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's ref.# (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NAVI-STAR¿ THERMO-COOL¿ ELECTROPHYSIOLOGY CATHETER
Type of Device
CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FLUTTER
Manufacturer (Section D)
BIOSENSE WEBSTER INC
31 technology drive, suite 200
irvine CA 92618
Manufacturer (Section G)
BIOSENSE WEBSTER INC (JUAREZ)
circuito interior norte
1820parque industrial salvacar
juarez 32599
MX   32599
Manufacturer Contact
michelleann garcia
31 technology dr
irvine, CA 92618
646591-798
MDR Report Key15324615
MDR Text Key298949058
Report Number2029046-2022-02041
Device Sequence Number1
Product Code OAD
UDI-Device Identifier10846835000559
UDI-Public10846835000559
Combination Product (y/n)N
Reporter Country CodeSZ
PMA/PMN Number
P030031
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Other
Type of Report Initial,Followup,Followup
Report Date 10/07/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/30/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberNI75TCDH
Device Catalogue NumberNI75TCDH
Device Lot Number30839799M
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? No
Date Manufacturer Received09/09/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured06/04/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
PENTARAY NAV ECO 7FR, F, 2-6-2
Patient Outcome(s) Required Intervention; Life Threatening;
-
-